WP
CVS icon

Waycross Partners’s CVS Health CVS Stock Holding History

Waycross Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,000
Closed -$3.57M – 86
2025
Q4 		$3.57M Hold
45,000
– – 0.29% 40
2025
Q3 		$3.39M Hold
45,000
– – 0.29% 39
2025
Q2 		$3.1M Buy
+45,000
New +$2.95M 0.29% 39
2024
Q4 		– Sell
-105,770
Closed -$6.65M – 64
2024
Q3 		$6.65M Sell
105,770
-101,769
-49% -$5.94M 0.92% 30
2024
Q2 		$12.3M Buy
207,539
+21,135
+11% +$1.32M 1.88% 24
2024
Q1 		$14.9M Buy
186,404
+13,447
+8% +$1.03M 2.56% 16
2023
Q4 		$13.7M Sell
172,957
-11,780
-6% -$838K 2.56% 16
2023
Q3 		$12.9M Buy
184,737
+164,737
+824% +$11.7M 2.85% 11
2023
Q2 		$1.38M Sell
20,000
-75
-0.4% -$5.34K 0.3% 49
2023
Q1 		$1.49M Sell
20,075
-12,400
-38% -$1.04M 0.43% 47
2022
Q4 		$3.03M Buy
32,475
+10,075
+45% +$972K 1.1% 31
2022
Q3 		$2.14M Buy
22,400
+10,000
+81% +$990K 1.44% 26
2022
Q2 		$1.15M Hold
12,400
– – 0.76% 45
2022
Q1 		$1.25M Hold
12,400
– – 0.73% 46
2021
Q4 		$1.28M Hold
12,400
– – 0.73% 49
2021
Q3 		$1.05M Hold
12,400
– – 0.66% 55
2021
Q2 		$1.03M Hold
12,400
– – 0.55% 53
2021
Q1 		$933K Hold
12,400
– – 0.52% 57
2020
Q4 		$847K Buy
+12,400
New +$807K 0.53% 52

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Waycross Partners's CVS Position: Q1 2026 in Review

Waycross Partners sold out of CVS Health (CVS) in Q1 2026, closing a stake of 45,000 shares — an estimated $3.57M sold.

Waycross Partners first reported a position in CVS in Q4 2020 and held it in 19 quarters. The position peaked at $14.9M in Q1 2024. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Waycross Partners reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Waycross Partners sold 45,000 CVS Health shares in Q1 2026, an estimated $3.57M.
  • Waycross Partners first reported a position in CVS Health in Q4 2020 and held it in 19 quarters.
  • Waycross Partners's CVS Health position peaked at $14.9M in Q1 2024.
  • 1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Waycross Partners's 13F filing for Q1 2026, filed 7 May 2026.